Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections Will be Virtual Boston USA March 6-10, 2021 Back

Tweet

COVID & HIV - Antiviral Molnupiravir, monoclonal antibody combinations, Convalesecent Plasma       CROI: COVID-19 HOSPITALIZATION AMONG PEOPLE WITH HIV OR SOLID ORGAN TRANSPLANT IN THE US - (03/09/21)   CROI: HIV AND COVID-19 INPATIENT OUTCOMES: A MATCHED RETROSPECTIVE MULTICENTRE ANALYSIS - (03/09/21)   CROI: In-Hospital COVID-19 Outcomes Not Worse With HIV in 6-Center UK Analysis - (03/09/21)   CROI: COMORBIDITY BURDEN IS ASSOCIATED WITH HOSPITALIZATION FOR COVID-19 AMONG PWH - (03/14/21)   CROI: COVID-19 IN HOSPITALIZED HIV-POSITIVE AND HIV-NEGATIVE PATIENTS: A MATCHED STUDY - (03/16/21)   CROI: PREVALENCE AND FACTORS ASSOCIATED WITH SARS-CoV-2 ANTIBODIES IN A SPANISH HIV COHORT - (03/16/21)   CROI: RISK FACTORS FOR HOSPITALIZATION IN PEOPLE WITH HIV AND COVID-19 - Denver (03/15/21)   CROI: CHARACTERIZING COVID-19 PRESENTATION AND CLINICAL OUTCOMES IN HIV PATIENTS IN THE US - (03/14/21)   CROI: COMORBIDITY BURDEN IS ASSOCIATED WITH HOSPITALIZATION FOR COVID-19 AMONG PWH - Atlanta (03/14/21)   CROI: Disrupted Gut Integrity, Other Gut Factors, Tied to COVID-19 Severity - Mark Mascolini - (03/10/21)   CROI: COVID & HIV - Antiviral Molnupiravir, monoclonal antibody combinations, Convalesecent Plasma - (03/19/21)   COVID Antiviral Molnupiravir, Antibodies, Convalesecent Plasma   CROI:CASIRIVIMAB WITH IMDEVIMAB ANTIBODY COCKTAIL FOR COVID-19 PREVENTION: INTERIM RESULTS - (03/15/21)   CROI: REDUCTION IN INFECTIOUS SARS-CoV-2 IN TREATMENT STUDY OF COVID-19 WITH MOLNUPIRAVIR - (03/10/21)   CROI: Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir - (03/14/21)   CROI: Convalescent Plasma Has No Effect on Survival or Disease Course With Severe COVID-19 - Mark Mascolini (03/10/21)   CROI: BAMLANIVIMAB+ETESEVIMAB FOR TREATMENT OF COVID-19 IN HIGH- RISK AMBULATORY PATIENTS - (03/10/21)   CROI: BAMLANIVIMAB PREVENTS COVID-19 MORBIDITY AND MORTALITY IN NURSING-HOME SETTING - (03/10/21)